1 study found for:    21506241 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: Copegus

Indicates status has not been verified in more than two years